4.6 Review

Hyperinflammatory Response in COVID-19: A Systematic Review

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome

Clovis Chabert et al.

Summary: This study identifies Aldo-Keto Reductase 1B10 (AKR1B10) as a key enzyme involved in the expression of pro-inflammatory cytokines in COVID-19. The increased expression of AKR1B10 is observed in lung samples from patients who died from COVID-19, and there is a significant link between AKR1B10 levels and disease severity. AKR1B10 can induce the expression of pro-inflammatory cytokines in macrophages and lung cells, and its inhibition can reduce cytokine production. Additionally, AKR1B10 can be secreted and transferred via extracellular vesicles, potentially contributing to the multi-organ systemic impact of COVID-19.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cell Biology

Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19

Aisha Tabassum et al.

Summary: Understanding the interaction between SARS-CoV-2, ACE2, bradykinin, and its metabolite des-Arg9-bradykinin is crucial in understanding the pathogenesis of COVID-19 and developing new treatment approaches.

MEDIATORS OF INFLAMMATION (2022)

Article Medicine, General & Internal

Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice

Jianxiong Zeng et al.

Summary: The study found that the NLRP3 inflammasome plays a crucial role in the lungs during SARS-CoV-2 infection, and inhibiting this inflammasome can reduce the release of pro-inflammatory cytokines related to COVID-19 in cells and mice. Therefore, targeting the NLRP3 inflammasome could be a promising immune intervention against severe COVID-19 disease.

EBIOMEDICINE (2022)

Article Physiology

Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness

Eric D. Morrell et al.

Summary: This study compared the immune characteristics of critically ill patients with and without COVID-19, and found significant differences in certain immune markers and decreased immune cell responsiveness in COVID-19 patients. The results highlight the importance of T-cell migration and immune checkpoint regulatory response in COVID-19-related critical illness.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2022)

Article Biochemistry & Molecular Biology

Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells

Remi Planes et al.

Summary: The activation of inflammasomes plays a crucial role in regulating the infection of SARS-CoV-2. Lung epithelial cells serve as the primary entry site of the virus and express the inflammasome-forming sensor NLRP1. The cleavage of NLRP1 by coronavirus 3CL proteases leads to inflammasome assembly, cell death, and reduced production of viral particles. Additionally, these proteases also inactivate the executioner protein Gasdermin D, promoting an alternative form of cell death called pyroptosis. Analysis of pyroptosis markers in COVID-19 patients suggests that GSDME/caspase-3 could potentially serve as markers of disease severity.

MOLECULAR CELL (2022)

Review Immunology

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons

Hayder M. Al-kuraishy et al.

Summary: HMGB1 is a multifunctional nuclear protein that plays a critical role in the inflammatory signaling pathway. Elevated levels of HMGB1 in COVID-19 patients are associated with disease severity and complications. Targeting the HMGB1 pathway may be beneficial in reducing the severity of the disease.

INFLAMMOPHARMACOLOGY (2022)

Article Microbiology

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-kappa B Activation

Hironori Nishitsuji et al.

Summary: This study reveals the molecular mechanisms behind the induction of proinflammatory cytokines by the SARS-CoV-2 virus. The NSP6 and ORF7a proteins activate the NF-kappa B pathway through interactions with TAK1. The polyubiquitination of NSP6 and ORF7a is essential for NF-kappa B activation, with TRIM13 and RNF121 playing key roles in this process. These findings provide novel insights into the pathogenesis of SARS-CoV-2 and the host immune response.
Article Immunology

Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β

Chiara Colarusso et al.

Summary: This study revealed that activation of the Absent in melanoma-2 (AIM2) inflammasome in COVID-19 long-haulers with lung fibrosis is associated with the release of IL-1 alpha, IFN-alpha, and TGF-beta. The release of IFN-alpha is caspase-1- and caspase-4-dependent, while the release of IL-1 alpha and TGF-beta is inflammasome independent. Higher expression of AIM2 in circulating CD14+ cells in PBMCs is correlated with lung fibrosis in COVID-19 patients.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

Neutrophil Extracellular Traps, Sepsis and COVID-19-A Tripod Stand

Esmeiry Ventura-Santana et al.

Summary: Severe COVID-19 affects about 20% of patients, leading to clinical manifestations such as ARDS and sepsis. The formation of neutrophil extracellular traps (NETs) is associated with severe cases. Understanding the immunopathology of COVID-19 is crucial for the development of effective therapies.

FRONTIERS IN IMMUNOLOGY (2022)

Review Public, Environmental & Occupational Health

Innate immunity to SARS-CoV-2 infection: a review

Marcos Jesse Abrahao Silva et al.

Summary: This study summarizes the immunopathological relationship of COVID-19 with innate immunity and evaluates the quality and bias risk of various studies, including clinical trials and research articles, using multiple assessment tools. It indicates that the innate immune response plays a crucial role in both primary defense and immune evasion by SARS-CoV-2.

EPIDEMIOLOGY AND INFECTION (2022)

Review Infectious Diseases

Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations

Andrea Marino et al.

Summary: The pathogenesis of COVID-19 involves early symptoms and late inflammatory response, with dysregulated immune response playing a crucial role in pulmonary damage. IL-6 plays a key role in inflammation development, and drugs targeting IL-6 can attenuate cytokine release. Sarilumab, an anti-IL-6 receptor antibody, may be a promising treatment for COVID-19.

INFECTIOUS DISEASE REPORTS (2022)

Review Hematology

Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system

Maria Grazia Lazzaroni et al.

Summary: COVID-19 is a new pandemic caused by SARS-Cov2 infection, with inflammation and the innate immune system playing key roles in the most severe cases. Abnormalities in coagulation parameters and platelets count have been reported, suggesting a subgroup of patients with poor prognosis. The cytokine storm and virus-specific mechanisms may also contribute to adverse outcomes in COVID-19.

BLOOD REVIEWS (2021)

Article Immunology

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

Tamara S. Rodrigues et al.

Summary: The active NLRP3 inflammasome in response to SARS-CoV-2 infection is associated with disease severity in COVID-19 patients, with higher levels of IL-18 and Casp1p20 correlating with poor clinical outcomes. These findings suggest that inflammasomes may serve as markers of disease severity and potential therapeutic targets for COVID-19.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Multidisciplinary Sciences

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

Rogan A. Grant et al.

Summary: The study found that patients infected with SARS-CoV-2 have enriched T cells and monocytes in the alveolar space, suggesting that the virus infects alveolar macrophages and induces T cell production of interferon-, leading to inflammation and persistent alveolitis.

NATURE (2021)

Review Cardiac & Cardiovascular Systems

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

Sean X. Gu et al.

Summary: Platelet and endothelial dysfunction are essential components of COVID-19 pathology, while cardiovascular risk factors exacerbate the severity of the disease. Patients with pre-existing cardiovascular disease and risk factors are at the highest risk of death from COVID-19.

NATURE REVIEWS CARDIOLOGY (2021)

Article Medicine, General & Internal

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

V. A. Simonovich et al.

Summary: There were no significant differences observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo in the treatment of severe Covid-19 pneumonia. The study results indicate that both groups had similar clinical outcomes and mortality rates after 30 days.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Pharmacology & Pharmacy

Netosis and Inflammasomes in Large Vessel Occlusion Thrombi

Stephanie H. Chen et al.

Summary: The inflammatory response plays a critical role in clotting in acute ischemic stroke (AIS), with neutrophil extracellular traps (NETs) being the major drivers of thrombosis. Inflammatory proteins are elevated in thrombi of AIS patients, contributing to poor outcomes following stroke.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis

Yili Liu et al.

Summary: Elevated plasma levels of IL-6, IL-8, and IL-5 were consistently found in deceased COVID-19 patients compared to those with mild/moderate or severe disease. The early plasma concentrations of IFN-a and IL-2 positively correlated with the length of the disease course. IL-6, IL-8, and IL-5 may play central roles in cytokine storms associated with COVID-19.

CYTOKINE (2021)

Article Biochemistry & Molecular Biology

The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients

Megan McAleavy et al.

MOLECULAR AND CELLULAR BIOLOGY (2021)

Article Immunology

The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression

Wei Huang et al.

Summary: COVID-19 is associated with immune dysregulation and cytokine storm, leading to altered levels of various immune cells and cytokines in the body. Some specific factors could potentially be used as biomarkers for predicting disease severity and progression.

JOURNAL OF IMMUNOLOGY (2021)

Article Immunology

High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019

Werner J. D. Ouwendijk et al.

Summary: Studies have shown that critically ill patients with COVID-19 have elevated levels of neutrophil extracellular traps (NETs) in their blood and respiratory tract samples. These NETs may contribute to the development of acute respiratory distress syndrome (ARDS) induced by SARS-CoV-2.

JOURNAL OF INFECTIOUS DISEASES (2021)

Review Medicine, Research & Experimental

Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications

Rishabh Hirawat et al.

Summary: COVID-19 is an unprecedented health crisis with its ease of transmission between humans and undetectability in the early stages making it particularly frightening. Characterized by pneumonia progressing to breathing difficulty, acute respiratory distress syndrome, and multi-organ failure, the excessive release of inflammatory mediators leading to cytokine storm is a potentially life-threatening phenomenon associated with this disease.

LIFE SCIENCES (2021)

Review Medicine, General & Internal

Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology

Shumpei Yokota et al.

Summary: The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, is believed to have originated from bats. The virus acts on human ACE2, leading to infections in cells and triggering an inflammatory response, which can result in a range of symptoms.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia

Luca Quartuccio et al.

Summary: In this study involving 67 hospitalized COVID-19 patients, IL-6, M-CSF, sIL-2R alpha, and HGF were found to be closely associated with respiratory insufficiency, indicating their potential involvement in the main biological processes of severe COVID-19.

CYTOKINE (2021)

Review Oncology

T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells

Yasmin Nouri et al.

Summary: TLRs expressed within T-cells serve as important costimulatory and regulatory molecules that enhance T-cell function and memory, while incorporating TLR signaling domains into CAR T-cells allows for the specific exploitation of T-cell intrinsic TLR function, presenting a new opportunity for cancer immunotherapies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Virology

Cytokine storm in severe COVID-19 pneumonia

Bengul Gursoy et al.

Summary: This study compared laboratory parameters of 150 confirmed COVID-19 patients with severe pneumonia, showing significant abnormalities in patients with pneumonia. Findings revealed marked changes in lymphocyte levels, LDH elevation, and other parameters in patients with severe pneumonia before and after its development. Additionally, a significant decrease in lymphocyte levels and increases in LDH, hs-troponin, procalcitonin, and triglyceride levels were observed in patients with worsened symptoms and developed ARDS in the ICU period.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Surgery

Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications

Jonathan P. Meizoso et al.

Summary: The COVID-19 pandemic poses a global public health threat with severe cases often marked by ARDS caused by microvascular thrombosis. The hypercoagulability and fibrinolysis shutdown seen in COVID-19 patients are distinctive features that require careful study for potential therapeutic interventions. Understanding the molecular mechanisms behind these dysfunctions is crucial for improving outcomes for severe COVID-19 patients.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)

Review Biochemistry & Molecular Biology

COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies

Habib Haybar et al.

Summary: The renin-angiotensin-aldosterone system and its metabolites, as well as the crosstalk between angiotensin, kinin-kallikrein system, inflammatory, and coagulation systems, play crucial roles in COVID-19. The study highlights the importance of therapeutic decisions, dosing, and laboratory monitoring in cardiac and anti-coagulant therapies for COVID-19 patients. Notably, factors such as the levels of D-dimer and fibrinogen, drug-drug interactions, and risk factors should be considered during thromboprophylaxis administration.

MOLECULAR BIOLOGY REPORTS (2021)

Article Cell Biology

Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy

Viseslav Popadic et al.

Summary: In this study of 160 consecutive critically ill COVID-19 patients, IL-6, serum albumin, and D-dimer at ICU admission, along with CT severity score, were identified as independent predictors of mortality.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Immunology

Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!

Francesca Coperchini et al.

Summary: SARS-COV-2 virus leads to a devastating pandemic, with cytokine-storm being a peculiar aspect of infection causing severe respiratory damage and multi-organ failure. IL-6, CXCL10, and macrophages play critical roles in the aberrant immune response, highlighting the importance of their interplay in the onset and progression of the cytokine storm in COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Neuropathophysiology of coronavirus dsease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection

Menizibeya O. Welcome et al.

Summary: COVID-19, caused by SARS-CoV-2, mainly affects the respiratory and gastrointestinal tracts but may also involve the central nervous system. Possible neuropathogenic mechanisms include downregulation of ACE2, increased activity of TMPRSS2 and cathepsin L, triggering neuroinflammatory response, and dysregulation of neurotransmitter signalling.

INFLAMMOPHARMACOLOGY (2021)

Article Infectious Diseases

Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study

Bin Zhu et al.

Summary: This study found a significant correlation between white blood cell count and death in COVID-19 patients, especially when the white blood cell count exceeded 6.16x10(boolean AND)9/L, the risk of death significantly increased.

BMC INFECTIOUS DISEASES (2021)

Article Virology

Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: A multi-center retrospective cohort study

Xia-Qing Li et al.

Summary: Acute kidney injury (AKI) is common in COVID-19 patients and is more prevalent in severe cases. Factors such as cytokine storm, ARDS, and kidney injury at admission play a significant role in the development of AKI. Long-term mechanical ventilation, cytokine storms, and secondary bacterial infections contribute to AKI-related mortality in COVID-19 patients.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Biochemistry & Molecular Biology

Role of arachidonic cascade in COVID-19 infection: A review

Md. Abdur Rahman Ripon et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2021)

Article Virology

Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction

Jiajia Wang et al.

Summary: Levels of inflammatory cytokines IL-6, IL-8, IL-10, and TNF-alpha are associated with the development of ARDS and extrapulmonary MOD in COVID-19 patients. These cytokine levels significantly increased in ARDS patients and correlated with coagulation parameters, DIC, kidney injury, and oxygenation levels. Non-survivors had higher levels of IL-6 and IL-10 compared to survivors.

VIROLOGY JOURNAL (2021)

Article Multidisciplinary Sciences

Cytokine signatures of end organ injury in COVID-19

Luis G. Gomez-Escobar et al.

Summary: The dysregulated immunologic response is believed to drive the severity of COVID-19. Research has found differences in inflammatory cytokines between COVID-19 patients and controls, predicting the development of ARDS, AKI, and mortality. Autopsies reveal histopathological changes in the lungs and kidneys of COVID-19 patients, offering insight into the pathogenesis of the disease and suggesting targeted treatment strategies.

SCIENTIFIC REPORTS (2021)

Article Immunology

SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells

Yujie Ren et al.

Summary: The membrane glycoprotein M encoded by SARS-CoV-2 induces apoptosis through interaction with PDK1, while the nucleocapsid protein N enhances M-induced apoptosis, emphasizing the pathogenic role of these two key proteins.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Review Immunology

Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies

Satoshi Gando et al.

Summary: Thromboplasminflammation in COVID-19 coagulopathy involves Ang II-induced coagulopathy, FXIIa- and kallikrein-enhanced fibrinolysis, and DIC, which all contribute to systemic inflammation through the production of inflammatory cytokines. The interplay between inflammation and serine protease networks exacerbates the pathologies of COVID-19 coagulopathy, causing microvascular thrombosis and bleeding in critically ill patients. Treatment targets include thrombin, plasmin, inflammation, and SARS-CoV-2 infection, with potential candidates for controlling these conditions.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages

Ioanna Pantazi et al.

Summary: The major cause of death in SARS-CoV-2 infected patients is deregulation of the innate immune system and development of cytokine storm. SARS-CoV-2 S protein can induce pro-inflammatory cytokine production in macrophages, potentially exacerbating inflammatory responses.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications

Behazine Combadiere et al.

Summary: Neutrophil subsets in COVID-19 patients have prognostic value in predicting disease severity and thrombosis complications.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The signal pathways and treatment of cytokine storm in COVID-19

Lan Yang et al.

Summary: The COVID-19 pandemic is a global crisis with devastating effects, where immunopathology plays a crucial role in disease progression, particularly the cytokine storm which has a significant impact on prognosis. Understanding and targeting the pathways involved in cytokine storm could lead to more effective treatment strategies for COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Cell & Tissue Engineering

P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation

Lyvia Lintzmaier Petiz et al.

Summary: The global SARS-CoV-2 pandemic has resulted in over 2.3 million deaths, and effective treatment for COVID-19 is still lacking. The differentiation of hematopoietic stem cells is affected by COVID-19, leading to immune cell activation, inflammation, and excessive release of reactive oxygen species, influencing neutrophil activity.

STEM CELL REVIEWS AND REPORTS (2021)

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Editorial Material Oncology

Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?

Dipak Panigrahy et al.

CANCER AND METASTASIS REVIEWS (2020)

Article Medicine, General & Internal

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

Kui Liu et al.

CHINESE MEDICAL JOURNAL (2020)

Review Biochemistry & Molecular Biology

COVID-19 cytokine storm: The anger of inflammation

Mehdi Mahmudpour et al.

CYTOKINE (2020)

Article Urology & Nephrology

Kidney disease is associated with in-hospital death of patients with COVID-19

Yichun Cheng et al.

KIDNEY INTERNATIONAL (2020)

Article Medicine, General & Internal

Impact of Coronavirus disease (COVID-19) pandemic on health professionals

Bilal Ahmed Sethi et al.

PAKISTAN JOURNAL OF MEDICAL SCIENCES (2020)

Article Critical Care Medicine

Characterization of the Inflammatory Response to Severe COVID-19 Illness

Oliver J. McElvaney et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Pharmacology & Pharmacy

What about COVID-19 and arachidonic acid pathway?

Malvina Hoxha

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation

Junyi Wang et al.

FASEB JOURNAL (2020)

Editorial Material Respiratory System

Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2

Chiara Robba et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)

Article Medicine, Research & Experimental

Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis

Jennifer G. Wilson et al.

JCI INSIGHT (2020)

Article Virology

The clinical course and its correlated immune status in COVID-19 pneumonia

Ruyuan He et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Review Medicine, Research & Experimental

Coronaviruses pathogenesis, comorbidities and multi -organ damage ? A review

Kaviyarasi Renu et al.

LIFE SCIENCES (2020)

Article Medical Laboratory Technology

Dynamic changes in routine blood parameters of a severe COVID-19 case

Guoguang Lu et al.

CLINICA CHIMICA ACTA (2020)

Article Immunology

Laboratory biomarkers associated with COVID-19 severity and management

S. Keddie et al.

CLINICAL IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Cytokine prediction of mortality in COVID19 patients

Mathilda Mandel et al.

CYTOKINE (2020)

Article Immunology

Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome

Lila Bouadma et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2020)

Article Medicine, General & Internal

Association of elevated inflammatory markers and severe COVID-19 A meta-analysis

Pan Ji et al.

MEDICINE (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation

Shufen Li et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Critical Care Medicine

CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS

Mathieu Blot et al.

CRITICAL CARE (2020)

Review Biochemistry & Molecular Biology

COVID-19: immunopathogenesis and Immunotherapeutics

Li Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Infectious Diseases

Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV

Shu-ren Li et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)

Review Medicine, Research & Experimental

High-Mobility Group Box 1 (HMGB1) and Autophagy in Acute Lung Injury (ALI): A Review

Lihua Qu et al.

MEDICAL SCIENCE MONITOR (2019)

Review Pharmacology & Pharmacy

Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling

Yam Nath Paudel et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2019)

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Editorial Material Pharmacology & Pharmacy

Soluble epoxide hydrolase: a new therapeutic target for depression

Kenji Hashimoto

EXPERT OPINION ON THERAPEUTIC TARGETS (2016)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Biochemistry & Molecular Biology

Neutrophil Elastase Promotes Interleukin-1β Secretion from Human Coronary Endothelium

Mabruka Alfaidi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Review Biochemistry & Molecular Biology

The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling

Karen Wagner et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2014)

Review Immunology

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling

Maricica Pacurari et al.

INTERNATIONAL JOURNAL OF INFLAMMATION (2014)

Review Microbiology

A decade after SARS: strategies for controlling emerging coronaviruses

Rachel L. Graham et al.

NATURE REVIEWS MICROBIOLOGY (2013)

Review Microbiology

Into the Eye of the Cytokine Storm

Jennifer R. Tisoncik et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)

Review Immunology

Expanding roles for CD4+ T cells in immunity to viruses

Susan L. Swain et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Article Pharmacology & Pharmacy

20-hydroxyeicosatetraenoic acid stimulates nuclear factor-kappa B activation and the production of inflammatory cytokines in human endothelial cells

Tsuneo Ishizuka et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Medicine, General & Internal

Hypertrophic scar formation following burns and trauma: New approaches to treatment

Shahram Aarabi et al.

PLOS MEDICINE (2007)

Article Nursing

The PICO strategy for the research question construction and evidence search

Cristina Mamedio da Costa Santos et al.

REVISTA LATINO-AMERICANA DE ENFERMAGEM (2007)

Article Biochemistry & Molecular Biology

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

K Kuba et al.

NATURE MEDICINE (2005)

Article Multidisciplinary Sciences

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Y Imai et al.

NATURE (2005)